ZD 1839

DRUG2 trials

Sponsors

Dana-Farber Cancer Institute, H. Lee Moffitt Cancer Center and Research Institute

Conditions

Esophageal CancerGastric CancerMetastatic Pancreatic Carcinoma

Phase 2

Docetaxel in Combination With Iressa in Previously Treated Patients With Pancreatic Cancer

CompletedNCT00137761

Dana-Farber Cancer InstituteMetastatic Pancreatic Carcinoma

Start: 2004-10-31End: 2009-03-31Updated: 2009-11-02

Cisplatin and Irinotecan Chemotherapy, Followed by ZD 1839 (Iressa) in Patients With Esophageal or Gastric Carcinomas

CompletedNCT00215995

H. Lee Moffitt Cancer Center and Research InstituteEsophageal Cancer, Gastric Cancer

Start: 2003-07-31End: 2007-05-31Updated: 2012-01-13